AHURAMEDICINA LIMITED
Opportunity 73/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: high (80/100)Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-05-30 | 2024-05-30 |
|---|---|---|
| Average employees | 0 | 0 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (18 events)Click to expand
- 2026-02-26📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-02-28📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-06-29📄gazette-filings-brought-up-to-dategazette · DISS40
- 2024-06-27📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-04-30📄gazette-notice-compulsorygazette · GAZ1
- 2023-05-02📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-02-21📄change-account-reference-date-company-previous-shortenedaccounts · AA01
- 2022-02-24📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-09-09📄gazette-filings-brought-up-to-dategazette · DISS40
- 2021-08-03📄gazette-notice-compulsorygazette · GAZ1
- 2021-02-23📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-09-07📄change-person-director-company-with-change-dateofficers · CH01
- 2020-02-27📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-02-27📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-08-08📄gazette-filings-brought-up-to-dategazette · DISS40
- 2018-08-07📄gazette-notice-compulsorygazette · GAZ1
- 2016-05-18🏢Company incorporatedAs AHURAMEDICINA LIMITED
- 2016-05-18➕ABAD, Hamzeh, Dr appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +No director turnover: Company is 10 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Hamzeh Abad Individual · Hungarian · DOB 09/1982 · age 44 | 75–100% | — | 75-100% shares | 01/04/2017 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · SK postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A PERSON CENTRED LTD→ 14809590 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| AL-SHIFA SERVICES LTD→ 15887181 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ALPINE PSYCHOLOGY LIMITED→ 13590023 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AMO AMAS LIMITED→ 07306612 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| AMUNCASTER HOLDINGS LTD→ 10451952 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| ANDREW CARE (WOODFORD) LTD→ 03986980 · est 2000 · no financials extracted | — | — | — | — | 25y | — | — |
| ANDREW CARE LTD→ 03762635 · est 1999 · no financials extracted | — | — | — | — | 26y | — | — |
| ANDREW KAYE (MANCHESTER) LIMITED→ 05556787 · est 2005 · no financials extracted | — | — | — | — | 20y | — | — |
| ANDREW PORTER RHEUMATOLOGY LTD→ 16719489 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ANDREW WINTER LTD→ 12303791 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ANGEL HEALTH LIMITED→ 16482781 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ANGEL HOME CARE SERVICE PRIVATE LIMITED→ 07925464 · est 2012 · no financials extracted | — | — | — | — | 14y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.